Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway

Cancer Letters

Volumn 313, Issue 2, 2011, Pages 181-191

  Pan, Xinhua ^a   Han, Honghui ^a   Wang, Lei ^a   Yang, Linli ^a   Li, Ruimei ^a   Li, Zhenxi ^a   Liu, Junchen ^a   Zhao, Qufei ^a   Qian, Min ^a   Liu, Mingyao ^a   Du, Bing ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Breast cancer; C Src FAK; Metastasis; Nitidine Chloride; Protrusion

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; NITIDINE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE P60; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOPHENANTHRIDINES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASES; RAC1 GTP-BINDING PROTEIN; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 82655162059     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.001     Document Type: Article

References (38)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
3. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 2010, 46:765-781.
4. Porter P.L. Global trends in breast cancer incidence and mortality. Salud ublica Mex. 2009, 51(Suppl. 2):s141-146.
5. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450.
6. Waterman-Storer C.M., Worthylake R.A., Liu B.P., Burridge K., Salmon E.D. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat. Cell Biol. 1999, 1:45-50.
7. Le Clainche C., Carlier M.F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol. Rev. 2008, 88:489-513.
8. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
9. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
10. Del Poeta M., Chen S.F., Von Hoff D., Dykstra C.C., Wani M.C., Manikumar G., Heitman J., Wall M.E., Perfect J.R. Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob. Agents Chemother. 1999, 43:2862-2868.
11. Hu J., Zhang W.D., Liu R.H., Zhang C., Shen Y.H., Li H.L., Liang M.J., Xu X.K. Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities. Chem. Biodivers. 2006, 3:990-995.
12. Gatto B., Sanders M.M., Yu C., Wu H.Y., Makhey D., LaVoie E.J., Liu L.F. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. Cancer Res. 1996, 56:2795-2800.
13. Cushman M., Mohan P., Smith E.C. Synthesis and biological activity of structural analogues of the anticancer benzophenanthridine alkaloid nitidine chloride. J. Med. Chem. 1984, 27:544-547.
14. Fan Y.J., Zhou J., Li M. Effect of nitidine chloride on the life cycle of Ehrlich ascites carcinoma cells in mice (author's transl). Zhongguo Yao Li Xue Bao 1981, 2:46-49.
15. Tan G.T., Lee S., Lee I.S., Chen J., Leitner P., Besterman J.M., Kinghorn A.D., Pezzuto J.M. Natural-product inhibitors of human DNA ligase I. Biochem. J. 1996, 314(Pt 3):993-1000.
16. Liu H., Ye D., Huang H., Wang X., Li D. Studies on pharmacokinetics of nitidine chloride in rabbits. Zhongguo Zhong Yao Za Zhi 2009, 34:1406-1409.
17. Wu J.C., Sundaresan G., Iyer M., Gambhir S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 2001, 4:297-306.
18. Weissleder R., Ntziachristos V. Shedding light onto live molecular targets. Nat. Med. 2003, 9:123-128.
19. Shan D., Chen L., Njardarson J.T., Gaul C., Ma X., Danishefsky S.J., Huang X.Y. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc. Natl. Acad. Sci. USA 2005, 102:3772-3776.
20. Han H., Du B., Pan X., Liu J., Zhao Q., Lian X., Qian M., Liu M. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Mol. Cancer Res. 2010, 8:1477-1488.
21. Fang W., Li H., Kong L., Niu G., Gao Q., Zhou K., Zheng J., Wu B. Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs. Beijing Da Xue Xue Bao 2003, 35:441-443.
22. Sato T., Koike L., Miyata Y., Hirata M., Mimaki Y., Sashida Y., Yano M., Ito A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 2002, 62:1025-1029.
23. Gerhardt H., Semb H. Pericytes: gatekeepers in tumour cell metastasis?. J. Mol. Med. 2008, 86:135-144.
24. Chiariello M., Marinissen M.J., Gutkind J.S. Regulation of c-myc expression by PDGF through Rho GTPases. Nat. Cell Biol. 2001, 3:580-586.
25. Kodama M., Kitadai Y., Sumida T., Ohnishi M., Ohara E., Tanaka M., Shinagawa K., Tanaka S., Yasui W., Chayama K. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor beta is associated with lymphatic metastasis in human gastric carcinoma. Cancer Sci. 2010, 101:1984-1989.
26. Ariad S., Seymour L., Bezwoda W.R. Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression. Breast Cancer Res. Treat. 1991, 20:11-17.
27. Tang Y., Olufemi L., Wang M.T., Nie D. Role of Rho GTPases in breast cancer. Front Biosci. 2008, 13:759-776.
28. Vial E., Sahai E., Marshall C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
29. Wong K., Ren X.R., Huang Y.Z., Xie Y., Liu G., Saito H., Tang H., Wen L., Brady-Kalnay S.M., Mei L., Wu J.Y., Xiong W.C., Rao Y. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001, 107:209-221.
30. Osmani N., Peglion F., Chavrier P., Etienne-Manneville S. Cdc42 localization and cell polarity depend on membrane traffic. J. Cell Biol. 2010, 191:1261-1269.
31. Xu L.H., Yang X., Bradham C.A., Brenner D.A., Baldwin A.S., Craven R.J., Cance W.G. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J. Biol. Chem. 2000, 275:30597-30604.
32. Cary L.A., Chang J.F., Guan J.L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 1996, 109(Pt 7):1787-1794.
33. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 2001, 1540:1-21.
34. Guarino M. Src signaling in cancer invasion. J. Cell Physiol 2010, 223:14-26.
35. Lin M.T., Lin B.R., Chang C.C., Chu C.Y., Su H.J., Chen S.T., Jeng Y.M., Kuo M.L. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int. J. Cancer 2007, 120:2600-2608.
36. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 1997, 89:1260-1270.
37. Scorilas A., Karameris A., Arnogiannaki N., Ardavanis A., Bassilopoulos P., Trangas T., Talieri M. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br. J. Cancer 2001, 84:1488-1496.
38. Nabeshima K., Inoue T., Shimao Y., Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 2002, 52:255-264.